Skip to main content
. 2022 Oct 22;12:17792. doi: 10.1038/s41598-022-20560-6

Table 2.

Functional properties of chimeric anti-PD-1 monoclonal antibodies.

Chimeric antibodies PD-1 binding activity, EC50 (ng/ml) PD-1/PD-L1 binding blockade activity, IC50 (ng/ml) Binding kinetics T cell activation
kon (1/Ms) koff (1/s) KD (nM) IFN-γ, EC50 (ng/ml) IL-2, EC50 (ng/ml)
xCUSB0103 18.90 593.4 6.53E + 05 2.92E−04 0.448 13.6 55.7
xCUSB0123 26.59 956.7 2.98E + 05 3.66E−04 1.230 N/A N/A
xCUSB0124 56.98 2,929 1.54E + 05 9.12E−04 5.920 N/A N/A
xCUSB0126 23.71 429.6 4.93E + 05 2.85E−04 0.577 77.7 219.1
xCUSB0129 18.67 454.8 4.71E + 05 2.93E−04 0.621 78.0 244.6
KEYTRUDA 10.33 227.7 6.71E + 05 4.019E−3 5.983 5.0 10.9
OPDIVO 10.57 460.9 1.92E + 05 1.397E−3 7.274 9.1 44.2

N/A Not available.